Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 142 for “"NKG2D"”.
-
NKG2D Ligands in Cancer
… have not been well elucidated. Because NKG2D is a major activating receptor on NK cells, we sought to test the hypothesis that NKG2D is the primary pathway in tumor cell recognition. Herein, we comprehensively assessed 20 cancer cell lines representing a broad array of cancer types. In …
-
Mechanisms of NKG2D ligand regulation
<p><strong>Background:</strong> The NKG2D ligands are a set of cell surface proteins, the expression of which can make cells susceptible to immunity mediated by NKG2D receptor expressing cells, which include NK cells, CD8<sup>+</sup> αβ T cells and γδ T cells. The NKG2D ligands are known to be …
-
Simultaneous Induction of Nkg2D and Nkg2D Ligand For Promoting Immune Surveillance By Il-12 Plus Doxorubicin Treatment
NKG2D (natural killer group 2, member D) and its ligands interaction in tumor microenvironment directs tumor infiltrating immune cells to recognize tumor cells, stimulate cytotoxic effector immune cells, and therefore eradicate tumor cells. IL-12, a cytokine produced by antigen presenting cells, …
-
Lymphomtherapie durch NKG2D-Aktivierung mittels bispezifischer Antikörper
… Rezeptor natural-killer group 2, member D (NKG2D) dar, der durch das Zusammenspiel mit seinen natürlichen Liganden sowohl die zytotoxische Aktivität von natürlichen Killer (NK)- als auch von T-Zellen reguliert. In der vorliegenden Arbeit wurden für die Identifizierung neuer bispezifischer …
-
Entwicklung NKG2D-gerichteter bispezifischer Antikörper zur Therapie des Multiplen Myeloms
… die Zelllyse auslösen. Triggermoleküle, wie NKG2D können sowohl NK-Zellen als auch T-Zellen rekrutieren und somit Immunantworten modulieren oder aktivieren. In dieser Arbeit wurde untersucht, inwieweit NKG2D als Triggermolekül in bispezifischen Antikörpern zur Aktivierung von Effektorzellen …
-
Potentiation of immunotherapy using an NKG2D adaptor CAR via CXCR2 armouring
… the activating natural killer cell group 2D (NKG2D) receptor. Human NKG2D recognises eight different stress ligands (NKG2DL) that are widely upregulated on cancer cells, notably in triple negative breast cancer (TNBC), colorectal cancer (CRC), epithelial ovarian cancer (EOC) and pancreatic …
-
Transcription regulation of two natural killer cell activating receptors, NKG2D and NCR1
… direct cytotoxicity and cytokine release. NKG2D and NCR1 are among the most studied NK receptors identified to date. NKG2D binds a range of stress induced MHC class I like ligands while NCR1 binds the viral protein, haemagglutinin, as well as unidentified tumour ligands. Knockout mouse …
-
Der NK-Zellrezeptor NKG2D als Zielstruktur für eine Antikörper-basierte therapeutische Immunmodulation
Das NKG2D (Natural Killer Group 2 Member D)-Protein, ist ein aktivierender Rezeptor, der es NK- und CD8+ T-Zellen ermöglicht, infizierte oder transformierte körpereigene Zellen zu erkennen und zu eliminieren. Eine Fehlregulation dieses Rezeptors auf Immunzellen scheint jedoch auch zur Ausbildung …
-
Characterising the immune synapse and function of NKG2D-based CAR T cells
… My PhD project investigates the IS formed by NKG2D ligand-targeting CAR T cells and explores how synapse architecture may be related to their anti-tumour activities. NKG2D is an immune-activating receptor that recognises a range of stress-inducible ligands, frequently upregulated on the …
-
THE ROLE OF INTERFERON REGULATORY FACTORS IN REGULATING THE EXPRESSION OF NKG2D LIGANDS
… mechanisms. It has been previously shown that NKG2D ligands are upregulated by the DDR in a p53-independent manner. We provide evidence in this study that the upregulation of NKG2D ligand expression in response to DNA damage depends on the serine/threonine kinase TBK1 and its phosphorylation …
-
Regulación epigenética de los ligandos de NKG2D. Implicaciones terapéuticas en leucemia mieloide aguda
… entre receptores de activación y de inhibición. NKG2D es uno de los principales receptores de activación de las células NK que también se expresa en células NKT, linfocitos T γδ y T αβ CD8+. Este receptor es capaz de reconocer múltiples ligandos (MICA, MICB, ULBPs1-6) expresados en situaciones de …
-
A new role for NKG2D signaling in CD8+ T cells and autoimmune diabetes
… is the receptor Natural-Killer-Group-2-Member-D (NKG2D), best known for its expression on natural killer (NK) cells and CD8+ T cells, where it recognizes NKG2D ligands expressed by stressed cells following viral infection or cancerous transformation. NKG2D is most well studied for its role in …
-
OMCP Mediated Cowpox Virulence and its Dependence on the Immune Receptors NKG2D and FCRL5.
… that OMCP binds the activating receptor NKG2D on NK cells as well as the orphan receptor FCRL5 on innate B cells. By using NKG2D-deficient, FCRL5-deficient, and wild type mice, as well as recombinant cowpox viruses lacking OMCP or expressing a mutated form of OMCP that does not bind …
-
The NKG2D/NKG2DL Pathway in CD8+ T Cell-Mediated Anti-Tumor Immunity and Immunotherapy
… MHC-agnostic and, instead, is mediated by T cell NKG2D engagement of NKG2D ligands on tumor cells. Subsequent tumor cell kill depends on prior TCR activation (albeit even by irrelevant antigen), revealing that adaptive priming can beget subsequent innate killing. This cytotoxicity mechanism is …
-
Studying the Antagonistic Relationship Between NKG2D and TGF-β Signaling in CD8+ T Cells
… granzyme B and perforin. On the other hand, NKG2D, a potent co-stimulatory receptor, has effects on CD8+ T cells opposite to that of TGF-?. In T cells from 22 healthy human donors, we found that the suppression by TGF-? was lower in most of the donors with higher expression levels of NKG2D. …
-
Untersuchungen der Tumordormanz und NKG2D-Liganden-Expression in zerebralen Metastasen des Mamma- und Bronchialkarzinoms
… Fluchtmechanismen, einschließlich des NKG2D-Rezeptor-Ligand-Systems, stellen potenzielle Mechanismen für Tumorrezidive dar. Bislang sind die immunologischen Eigenschaften dormanter Tumorzellen in Bezug auf das NKG2D-System bei zerebralen Metastasen größtenteils unbekannt. In der …
-
Novel allogeneic CAR-T cell therapy targeting NKG2D ligands: universal immunotherapy against solid and haematological tumours
… transduction to introduce an atypical CAR, NKG2D-CAR, which targets eight different ligands commonly upregulated in both solid and haematological tumours, theoretically being less prone to tumour resistance and relapse. The novel CAR-T cell prototype was optimized through testing different …
-
Perioperative Genexpression von CD 94 (KLRD1), NKG2D und Granulysin zytotoxischer Lymphozyten als prädiktive Marker einer postoperativen Sepsis
… Analyse wurde die Genexpression von Granulysin, NKG2D und KLRD1 von Patienten, die eine postoperative schwere Sepsis entwickeln mit derjenigen von Patienten, die bei vergleichbarem Trauma keine Sepsis entwickelten, verglichen. Hierzu wurde insgesamt 220 Patienten, die sich größeren abdominal- …
Page 1 of 8